ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,986,366 | -27.3% | 139,870 | -5.9% | 0.15% | -20.3% |
| Q2 2023 | $6,856,948 | +15.0% | 148,644 | -0.0% | 0.19% | +8.7% |
| Q1 2023 | $5,962,349 | +89076.6% | 148,687 | +3.0% | 0.17% | -18.1% |
| Q4 2022 | $6,686 | -99.9% | 144,306 | +21.3% | 0.21% | +31.2% |
| Q3 2022 | $4,925,000 | -34.2% | 118,929 | -5.2% | 0.16% | -29.2% |
| Q2 2022 | $7,488,000 | -17.9% | 125,506 | -0.1% | 0.23% | +4.6% |
| Q1 2022 | $9,121,000 | – | 125,604 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |